Protagenic Therapeutics Stock Target Price and Analyst Consensus
| PTIX Stock | USD 0.65 0.04 6.56% |
The current analyst and expert consensus on Protagenic Therapeutics is Buy, with no strong buy opinions. The current projected Protagenic Therapeutics target price consensus is 4.00 with 1 analyst opinions. Check out Macroaxis Advice on Protagenic Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.The most common way Protagenic Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Protagenic Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Protagenic Therapeutics. We encourage you to use your own analysis of Protagenic Therapeutics to validate this buy or sell advice. Protagenic Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Protagenic Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 9.0272.
Lowest Forecast 3.64 | Highest Forecast 4.44 | Target Price 4 |
Protagenic |
It's important to approach Protagenic Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Protagenic Therapeutics price targets
Protagenic Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Protagenic Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Protagenic Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Protagenic Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Protagenic Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Protagenic Therapeutics is a key component of Protagenic Therapeutics valuation and have some predictive power on the future returns of a Protagenic Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Gambling Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | Warren Buffett Holdings Invested over 40 shares | |
 | Investor Favorites Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Chemicals Invested over 30 shares | |
 | Manufacturing Invested over 30 shares | |
 | Hedge Favorites Invested few shares |
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.